Literature DB >> 1690237

Altered expression of self-reactive T cell receptor V beta regions in autoimmune mice.

J D Mountz1, T M Smith, K S Toth.   

Abstract

Intrathymic tolerance results in elimination of T cells bearing self-reactive TCR V beta regions in mice expressing certain combinations of I-E and minor lymphocyte stimulatory (Mls) phenotypes. To determine if autoimmune strains of mice have a defect in intrathymic deletion of self-reactive TCR V beta regions, expression of V beta 3, V beta 6, V beta 8.1, and V beta 11 were examined in lpr/lpr and +/+ strains of mice; MRL/MpJ(H-2K, I-E+, Mlsb,), C57BL/6J(H-2b, I-E-, Mlsb,), C3H/HeJ(H-2k, I-E+, Mlsc), AKR/J(H-2k, I-E+, Mlsa); and in autoimmune NZB/N(H-2d, I-E+, Mlsa) and BXSB(H-2b, I-E-, Mlsb) mice. The results suggest that, during intrathymic development, self-reactive T cells are deleted in autoimmune strains of mice as found in normal control strains of mice. However, the TCR V beta repertoire is skewed in autoimmune strains compared to normal strains of mice. For example, MRL-lpr/lpr mice, but not other lpr/lpr strains, had increased expression of V beta 6 relative to expression in control MRL(-)+/+ mice, which is associated with collagen-induced arthritis. These data are consistent with a model of normal affinity for negative selection of self-reactive T cells in the thymus of autoimmune strains of mice followed by expansion of autoreactive T cell clones in the peripheral lymphoid organs. The peripheral lymphoid organs of lpr/lpr mice contain an expanded population of abnormal CD4-, CD8-, 6B2+ T cells. Elimination of self-reactive peripheral T cells suggests that these abnormal cells are derived from a CD4+ subpopulation in the thymus. Flow cytometry analysis of peripheral lymph node T cells from MRL-lpr/lpr mice reveal three populations of CD4+ T cells expressing low, intermediate and high intensity of B220 (6B2). This supports the hypothesis that in lpr/lpr mice, self-reactive CD4+ T cells are eliminated in the thymus, and that these cells lose expression of CD4 and acquire expression of 6B2 in the periphery.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1690237

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  Kinetics of Fas-induced apoptosis in thymic organ culture.

Authors:  T Zhou; M Fleck; U Müeller-Ladner; P Yang; Z Wang; S Gay; S Matsumoto; J D Mountz
Journal:  J Clin Immunol       Date:  1997-01       Impact factor: 8.317

2.  Fas (CD95/APO-1) limits the expansion of T lymphocytes in an environment of limited T-cell antigen receptor/MHC contacts.

Authors:  Karen A Fortner; Rosemary K Lees; H Robson MacDonald; Ralph C Budd
Journal:  Int Immunol       Date:  2011-01-25       Impact factor: 4.823

3.  Apoptosis with FasL+ cell infiltration in the periphery and thymus of corrected autoimmune mice.

Authors:  T Kobata; K Takasaki; H Asahara; N M Hong; K Masuko-Hongo; T Kato; S Hirose; T Shirai; N Kayagaki; H Yagita; K Okumura; K Nishioka
Journal:  Immunology       Date:  1997-10       Impact factor: 7.397

4.  Apoptosis regulators Fas and Bim synergistically control T-lymphocyte homeostatic proliferation.

Authors:  Karen A Fortner; Philippe Bouillet; Andreas Strasser; Ralph C Budd
Journal:  Eur J Immunol       Date:  2010-10-27       Impact factor: 5.532

5.  Identification of systemically expanded activated T cell clones in MRL/lpr and NZB/W F1 lupus model mice.

Authors:  G Zhou; K Fujio; A Sadakata; A Okamoto; R Yu; K Yamamoto
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

Review 6.  Analysis of the immune system with transgenic mice: T cell development.

Authors:  H Bluethmann
Journal:  Experientia       Date:  1991-09-15

Review 7.  Analysis of gene profile, steady state proliferation and apoptosis of double-negative T cells in the periphery and gut epithelium provides new insights into the biological functions of the Fas pathway.

Authors:  Abdel Rahim A Hamad
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

8.  Correction of accelerated autoimmune disease by early replacement of the mutated lpr gene with the normal Fas apoptosis gene in the T cells of transgenic MRL-lpr/lpr mice.

Authors:  J Wu; T Zhou; J Zhang; J He; W C Gause; J D Mountz
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

9.  The potential of Fas ligand (apoptosis-inducing molecule) as an unconventional therapeutic target in type 1 diabetes.

Authors:  Abdel Rahim A R Hamad; Kristin Arcara; Sophia Uddin; Thomas Donner
Journal:  Front Immunol       Date:  2012-07-12       Impact factor: 7.561

10.  A role for Fas in negative selection of thymocytes in vivo.

Authors:  H Kishimoto; C D Surh; J Sprent
Journal:  J Exp Med       Date:  1998-05-04       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.